• The Global Vaccine Impact Conference closed today, as the Vaccine Alliance marked more than 1 billion children vaccinated through its programmes – while looking to the future and focusing on the power of innovation and collaboration to tackle challenges in the post-pandemic era.

  • Hosted by the Spanish Government, the Conference brought together more than 20 heads of state and ministers as well as private sector innovators, civil society and the pharmaceutical industry, to evaluate the Alliance’s implementation of first two years of its current strategic period and deepen their commitment to routine immunisation and life-saving vaccinations.

  • José Manuel Albares, Spanish Minister of Foreign Affairs, European Union and Cooperation, spoke as Spain prepares to take up the rotating EU presidency: “As co-hosts of the Gavi Mid Term Review, Spain has renewed its firm commitment to the Vaccine Alliance and to global health. Spain’s leadership role in Gavi is a testament of the solidarity and engagement both of the Spanish Government as well as of Spanish civil society.”

Geneva/Madrid, 15 June 2023 – The Global Vaccine Impact Conference in Madrid was an important convening of global leaders to evaluate the past two years of implementation of the Vaccine Alliance’s five-year strategy against the complex backdrop of COVID-19, and to set out a strong new commitment to vaccination as Gavi, the Vaccine Alliance passed the mark of 1 billion children vaccinated since its founding in 2000. The Conference, convened by Spain’s Minister for Foreign Affairs, European Union and Cooperation, José Manuel Albares, saw health ministers from 17 Gavi implementing countries and officials from 23 donor countries renew their commitment to work together, build on the successes of the past two years, tackle ongoing challenges, and harness innovation and collaboration to unleash the power of vaccination.

This came as Gavi published its new Mid-Term Review report, Raising Generation ImmUnity, which looked at data from the first two years of the Alliance’s 2021-2025 strategic period. The report charted progress against the 2019 Investment Opportunity and showed that the Vaccine Alliance is on track to meet the majority of the key commitments made to donors. This includes supporting countries to immunise an additional 300 million children by 2025, saving more than seven million lives and generating economic benefits of US$ 80-100 billion. It also showed that countries are facing more challenges in transitioning out of Gavi support, for reasons that include the COVID-19 pandemic and other economic shocks. After a drop in routine immunisation during the pandemic, it also noted a recovery of vaccination in Gavi-supported countries in 2022, though more must be done to reach children who missed out during the pandemic.

“As co-hosts of the Gavi Mid Term Review, Spain has renewed its firm commitment to the Vaccine Alliance and to global health. Spain’s leadership role in Gavi is a testament of the solidarity and engagement both of the Spanish Government as well as of Spanish civil society,” said José Manuel Albares, Spanish Minister of Foreign Affairs, European Union and Cooperation.

Against an increasingly complex operating environment for global vaccination, close to 250 participants from governments, international organisations, civil society and the private sector discussed the progress and challenges of the Alliance over the past two years and the areas requiring increased emphasis in the near future. Health Ministers from Africa, Asia and Latin America spoke about their successes in working across the Vaccine Alliance to grow vaccination over the past two decades, but also challenges posed by the pandemic, by instability and by climate change. Along with private sector partners and civil society, attendees came together to stress the power of innovation and community engagement in reaching more children with life-saving vaccinations (full programme here).

“A whole generation of young adults are alive and healthy in India thanks to the power of immunisation – let us aspire to achieve even more for today’s children,” said H.E. Dr Mansukh Mandaviya, Minister of Health and Family Welfare, India

"Immunisation programmes are an investment in human capital. They improve public health, life expectancy, and work performance. They are a downpayment for future economic prosperity," said  Hon. Austin Demby, Minister of Health and Sanitation, Sierra Leone.

At the Global Vaccine Impact Conference, the Republic of Korea pledged US$ 70 million to allow Gavi to continue its efforts to fight against COVID-19; this funding could also support wider efforts by Gavi to make sure the world is better prepared for the next pandemic. This pledge is part of a 2022 commitment of US$ 300 million to the Access to COVID-19 Tools (ACT) Accelerator.

The summit also saw Gavi and the European Investment Bank announce the extension of EIB’s support beyond COVAX to frontload grants to Gavi to boost routine and outbreak vaccination programmes more quickly, thereby effectively bringing forward signed donor grants and immediately converting them to available funds. Allowing Gavi to accelerate funding across its broad vaccination efforts, EIB’s Board has approved a EUR 1 billion financing facility to be available to all sovereign donors. This facility goes beyond providing immediate liquidity from traditional grants by accepting contingent grants once those conditions have been met.

“With a new sovereign donor pledge from the Republic of Korea and an extension of support from the European Investment Bank, we are prepared to respond to future health crises and pandemics right away,” said Prof José Manuel Barroso, Gavi Board Chair. “We also welcome a number of private sector, civil society and philanthropic partnerships, many of which are supported by Gavi’s Matching Fund thanks to our donors. Investing in innovation means faster delivery and new tools to help reach more people more quickly.”

“Today, I have the pleasure to announce Korea's renewed commitment to Gavi. My government will contribute 70 million dollars this year, in alignment with our previous commitment of 300 million US dollars to the Access to COVID-19 Tools Accelerator (ACT-A) from 2023 to 2025. My government is convinced that this contribution will play a crucial role in supporting the ongoing battle against the lingering COVID-19 pandemic. Building on the lessons learned, our support will go beyond COVID-19 immunization efforts. It will include strengthening health systems and reinforcing communities' basic capabilities to combat not only the current crisis but also future challenges more effectively,” said H.E. Mr Bahk Sahng-hoon, Ambassador Extraordinary and Plenipotentiary to the Kingdom of Spain, Republic of Korea, on behalf of the Foreign Minister of Korea.

“Accelerated access to finance is not only critical to pandemic response, but for greater impact in routine immunisation programmes. As part of Team Europe, the European Investment Bank has expanded support to Gavi by approving a EUR 1 billion package, providing Gavi and its donors with the financial power and flexibility for the future,” said Thomas Östros, Vice President of the European Investment Bank.

A number of innovative partnerships with private sector, philanthropy and development finance partners were announced at the conference, many of which were matched through the Gavi Matching Fund, which is supported by the United Kingdom, the Netherlands and the Bill & Melinda Gates Foundation.

“Food shortages and infectious diseases cause millions of deaths around the world each year which can be prevented. By matching the Children’s Investment Fund Foundation investment, the UK is helping provide vaccines and nutrition services to around two million women and children in Ethiopia,” U.K. Minister for Development and Africa Andrew Mitchell said. “This project’s two-pronged approach of immunising people and giving them lifesaving nutrition services will reach vulnerable communities efficiently. By working with our global health partners we can help end preventable deaths for good.”

“The Netherlands is proudly supporting Gavi Matching Fund, bringing together different partners to contribute to access to vaccines and quality of health. The new programmes supported through the Matching Fund bring innovate solutions for immunization and healthcare, often using digital opportunities, engaging communities and thinking integrated and multisectoral,” said H.E. Pascalle Grotenhuis, Vice-Minister for Development Cooperation of the Netherlands.

Pledges included:

  • The Children's Investment Fund Foundation (CIFF) and Gavi announced a US$ 30m co-investment to reach zero dose children through an integrated immunisation, nutrition, and social protection programme in Ethiopia. The unique initiative, implemented by UNICEF, will extend the reach of joint service delivery to help address the dual burden of malnutrition and infectious disease.1
  • Girl Effect unveiled a US $8 million partnership that will expand the current collaboration with Gavi to bring integrated health services with a focus on routine immunization and the HPV vaccine to remote zero dose communities in Tanzania. Girl Effect will also launch a new programme to support the Government of India in its plan to launch the HPV vaccine, driving uptake of the HPV vaccine through parents, teachers, and health workers.2
  • Gavi and Integrate Health announced a US$ 6 million partnership to reach Zero Dose children in rural Guinea, in close collaboration with the Ministry of Health. The innovative approach integrates professional Community Health Workers with improved care in public clinics, a powerful combination that enables the detection and care of Zero Dose and under-vaccinated children. Integrate Health will pilot their approach in the Kouroussa district, evaluate what works, and scale successful innovations nationwide.3
  • The Church of Jesus Christ of Latter-day Saints committed US$ 3 million, doubled by the Matching Fund, to strengthen the Alliance’s efforts to vaccinate children across Africa against malaria in advance of vaccine rollouts later this year. 4
  • The Eleanor Crook Foundation announced a US$ 2 million partnership, towards NutriVax, an implementation research partnership that aims to generate evidence on the interplay between nutrition services and demand for vaccines in Nigeria.5
  • Omnicom, an inter-connected global network of leading marketing communications, provided US$ 1.5 million in-kind support to Gavi, supporting Gavi’s communication and engagement efforts and its mission to accelerate equitable access to immunisation.
  • In honour of the 15 year celebration of the partnership for immunisation between “la Caixa” Foundation and Gavi, “la Caixa” Foundation reaffirmed its commitment to continue supporting Gavi’s vaccination programmes through the Alliance for Children’s Vaccination.
  • Arm renewed their commitment to Gavi’s ‘INFUSE’ innovation programme, again doubled by the Matching Fund and backed by the United Kingdom, which will extend the benefits of technology and innovation to improve immunisation programmes in Gavi supported countries.

Additionally, the U.S. International Development Finance Corporation (DFC), in partnership with Gavi, announced it is seeking opportunities to expand their existing partnership to support a range of critical immunisation efforts, including COVID-19, routine childhood, and potential outbreak vaccines.

“As we emerge from the public health emergency, we see cause for both optimism and concern: routine immunisation is showing signs of recovery and Gavi is on track to meet most of its goals for the 2021-2025 period, but too many children still miss out on life-saving vaccinations,” said Dr Seth Berkley, Gavi CEO. “We thank the Spanish Government for bringing people together to re-commit to immunisation in the years to come. We’ve spent the past 23 years raising Generation ImmUnity – as another generation comes of age, we aim to protect even more children against even more diseases.”

“Routine immunisation by Gavi has enhanced the foundation of UHC that Japan has pursued. In G7 Hiroshima Summit, the G7 announced the G7 Hiroshima Vision for Equitable Access to MCMs, stressing the importance of equity, inclusivity and other principles. Based on this Vision, the G7 launched the MCM Delivery Partnership. Japan will work with and within Gavi, an essential actor for these efforts,” said H.E. Fumio Kishida, Prime Minister of Japan.


Download: English | French


Evan O’Connell
+41 79 682 18 95

Meg Sharafudeen
+41 79 711 55 54

Collins Weru Mwai
+25 078 783 66 38

Cirũ Kariũki
+41 79 913 94 41

Laura Shevlin
+ 41 79 529 92 87



Subscribe to our newsletter